A Study to Test Bioavailability of of 2 New Formulations of UCB0599 in Healthy Participants in Part A and to Test Safety, Tolerability, and Pharmacokinetic (PK) of UCB0599 in Healthy Japanese and Chinese Participants in Part B

Clinical trial NCT05845645 · COMPLETED

Trial details

NCT number: NCT05845645
Sponsor: UCB Biopharma SRL
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Study Participants

Start date: 2023-05-31
Primary completion: 2024-04-13
Enrollment: 73

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.